Endothelial function, vascular reactivity and gender differences in the cardiovascular system.

Time for primary review 40 days. A marked gender difference exists in the prevalence and severity of cardiovascular disease, even after adjustment for traditional vascular risk factors, which are more prevalent in males [1]. This has led to an interest in the role of sex steroids themselves in the promotion or inhibition of atherogenic events. As endothelial dysfunction is an early and important event in atherogenesis [2] and appears to predict adverse coronary outcomes [3], gender differences in endothelial function and the effects of hormonal therapy on vascular function have been the focus of considerable research interest. The normal vascular endothelium regulates arterial tone, platelet and leukocyte interactions, coagulation, fibrinolysis and vascular growth [4]. Measurement of endothelial function in the systemic arteries has become established as an important method for the detection of early (pre-symptomatic) arterial abnormalities in humans [5]. Ultrasound-detected endothelial dysfunction in peripheral arteries correlates significantly with coronary endothelial dysfunction [6], as well as with the extent and severity of coronary atherosclerosis [7]. The availability of a non-invasive method for the reproducible measurement of endothelium-dependent dilatation has facilitated the study of the interactions between sex hormones and arterial function, in both males and females. The normal vascular endothelium is only one cell layer thick, separating the blood and vascular smooth muscle. The endothelium responds to physical and chemical stimuli via the synthesis and/or release of regulatory substances affecting vascular tone and growth, thrombosis and thrombolysis and platelet and leukocyte interactions with the endothelium. Substances released by the endothelium include nitric oxide (NO), prostacyclin, endothelins, interleukins, endothelial growth factors, adhesion molecules, plasminogen inhibitors and von Willebrand factor [4,8–10]. The pivotal role of the endothelium in regulating vascular smooth muscle tone has only recently been appreciated [11]. The existence of an endothelium-derived … * Corresponding author. Tel.: +61-2-9515-6519; fax: +61-2-9550-6262 davidc{at}card.rpa.cs.nsw.gov.au

[1]  A. Dart,et al.  Aromatase inhibition alters vascular reactivity and arterial compliance in men: a possible vascular role for endogenous sex hormones in males. , 1999, Australian and New Zealand journal of medicine.

[2]  N. Andersson LONG-TERM EFFECTS OF METHYL ISOCYANATE , 1989, The Lancet.

[3]  D. Charnock-Jones,et al.  Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. , 1996, The Journal of clinical investigation.

[4]  A M Zeiher,et al.  Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. , 1993, The Journal of clinical investigation.

[5]  P. Bray,et al.  Human megakaryocytes and platelets contain the estrogen receptor beta and androgen receptor (AR): testosterone regulates AR expression. , 2000, Blood.

[6]  P. Vanhoutte Endothelium and Control of Vascular Function State of the Art Lecture , 1989, Hypertension.

[7]  P. Ganz,et al.  Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. , 1986, The New England journal of medicine.

[8]  M. Anthony,et al.  Soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques. , 1997, Fertility and sterility.

[9]  O. Raitakari,et al.  Testing for endothelial dysfunction , 2000, Annals of medicine.

[10]  R. Machovich Choices among the Possible Reaction Routes Catalyzed by Thrombin a , 1986, Annals of the New York Academy of Sciences.

[11]  H. Teede,et al.  Evidence that parenteral testosterone therapy may improve endothelium-dependent and -independent vasodilation in postmenopausal women already receiving estrogen. , 2001, The Journal of clinical endocrinology and metabolism.

[12]  A. Sulli,et al.  Androgen and estrogen receptors are present in primary cultures of human synovial macrophages. , 1996, The Journal of clinical endocrinology and metabolism.

[13]  C. Dollery,et al.  Role of endothelium in the maintenance of low pulmonary vascular tone in normal children. , 1994, Circulation.

[14]  D. Glogar,et al.  Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. , 1997, Atherosclerosis.

[15]  E. Jaffe,et al.  Cell biology of endothelial cells. , 1987, Human pathology.

[16]  H. White,et al.  Association between Polycystic Ovaries and Extent of Coronary Artery Disease in Women Having Cardiac Catheterization , 1997, Annals of Internal Medicine.

[17]  H. Hidaka,et al.  Estrogen increases endothelial nitric oxide by a receptor-mediated system. , 1995, Biochemical and Biophysical Research Communications - BBRC.

[18]  David Handelsman,et al.  Androgen receptor expression is greater in macrophages from male than from female donors. A sex difference with implications for atherogenesis. , 2000, Circulation.

[19]  J. Viikari,et al.  Constantly low HDL-cholesterol concentration relates to endothelial dysfunction and increased in vivo LDL-oxidation in healthy young men. , 1999, Atherosclerosis.

[20]  A. Quyyumi,et al.  Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. , 1994, Circulation.

[21]  P. Ganz,et al.  Estrogen Improves Endothelium-Dependent, Flow-Mediated Vasodilation in Postmenopausal Women , 1994, Annals of Internal Medicine.

[22]  C. Hayward,et al.  Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease. , 1999, Circulation.

[23]  G. New,et al.  Acute administration of 17beta-oestradiol does not improve endothelium-dependent vasodilatation in young men. , 1999, Clinical science.

[24]  J. Monier,et al.  Specific estrogen binding sites in human lymphoid cells and thymic cells. , 1983, Journal of steroid biochemistry.

[25]  D. Celermajer,et al.  Androgen deprivation is associated with enhanced endothelium-dependent dilatation in adult men. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[26]  S. Rajagopalan,et al.  Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. , 1997, Circulation.

[27]  D. Celermajer,et al.  Normal ranges for brachial artery flow-mediated dilatation: A non-invasive ultrasound test of arterial endothelial function , 1996 .

[28]  S. Sordello,et al.  Vascular endothelial growth factor is up-regulated in vitro and in vivo by androgens. , 1998, Biochemical and biophysical research communications.

[29]  A. Bonev,et al.  Gender differences in coronary artery diameter involve estrogen, nitric oxide, and Ca(2+)-dependent K+ channels. , 1996, Circulation research.

[30]  D. Celermajer,et al.  Endothelial dysfunction: does it matter? Is it reversible? , 1997, Journal of the American College of Cardiology.

[31]  M. Mendelsohn,et al.  Protective effects of estrogen on the cardiovascular system. , 1999, The American journal of cardiology.

[32]  J. Simons,et al.  Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women. , 2000, The American journal of cardiology.

[33]  J. Marín,et al.  Chronic treatment with the anabolic steroid, nandrolone, inhibits vasodilator responses in rabbit aorta. , 1994, European journal of pharmacology.

[34]  L. Mosekilde,et al.  Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function. , 1998, Circulation.

[35]  M. Sugimachi,et al.  Effects of Age on Endothelium‐Dependent Vasodilation of Resistance Coronary Artery by Acetycholine in Humans , 1993, Circulation.

[36]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[37]  R Busse,et al.  Crucial role of endothelium in the vasodilator response to increased flow in vivo. , 1986, Hypertension.

[38]  David Handelsman,et al.  Androgenic anabolic steroids and arterial structure and function in male bodybuilders. , 2001, Journal of the American College of Cardiology.

[39]  David Handelsman,et al.  Vascular reactivity is impaired in genetic females taking high-dose androgens. , 1998, Journal of the American College of Cardiology.

[40]  H. Drexler,et al.  Endothelial Function in Human Coronary Arteries In Vivo: Focus on Hypercholesterolemia , 1991, Hypertension.

[41]  R. White,et al.  Estrogen relaxes coronary arteries by opening BKCa channels through a cGMP-dependent mechanism. , 1995, Circulation research.

[42]  P. Rogers,et al.  Endometrial vascular smooth muscle oestrogen and progesterone receptor distribution in women with and without menorrhagia. , 1996, Human reproduction.

[43]  S. Higano,et al.  Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. , 2000, Circulation.

[44]  David Handelsman,et al.  Oestradiol improves arterial endothelial function in healthy men receiving testosterone , 2001, Clinical endocrinology.

[45]  W E Haefeli,et al.  Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. , 1995, Circulation.

[46]  S. Moncada,et al.  EFFECTS OF ENDOTHELIUM-DERIVED NITRIC OXIDE ON PERIPHERAL ARTERIOLAR TONE IN MAN , 1989, The Lancet.

[47]  M. Taskinen,et al.  Differential Effects of Oral and Transdermal Estrogen Replacement Therapy on Endothelial Function in Postmenopausal Women , 2000, Circulation.

[48]  K. Kugiyama,et al.  Gender difference in improvement of endothelium-dependent vasodilation after estrogen supplementation. , 1997, Journal of the American College of Cardiology.

[49]  A. Grace,et al.  Tamoxifen Effects on Endothelial Function and Cardiovascular Risk Factors in Men With Advanced Atherosclerosis , 2001, Circulation.

[50]  P. Ganz,et al.  Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women. , 1998, Circulation.

[51]  G. Figtree,et al.  Raloxifene acutely relaxes rabbit coronary arteries in vitro by an estrogen receptor-dependent and nitric oxide-dependent mechanism. , 1999, Circulation.

[52]  A. Yeung,et al.  The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. , 1995, The New England journal of medicine.

[53]  Stamatis Adamopoulos,et al.  17β-Estradiol Attenuates Acetylcholine-Induced Coronary Arterial Constriction in Women but Not Men With Coronary Heart Disease , 1995 .

[54]  P. Poole‐Wilson,et al.  Testosterone relaxes rabbit coronary arteries and aorta. , 1995, Circulation.

[55]  Z. Rymaszewski,et al.  Antioxidant potential of specific estrogens on lipid peroxidation , 1993 .

[56]  G. Garcı́a-Cardeña,et al.  17 beta-estradiol regulation of human endothelial cell basal nitric oxide release, independent of cytosolic Ca2+ mobilization. , 1997, Circulation research.

[57]  A M Zeiher,et al.  Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. , 2000, Circulation.

[58]  W. Walters,et al.  Arterial reactivity is enhanced in genetic males taking high dose estrogens. , 1997, Journal of the American College of Cardiology.

[59]  B. Mitlak,et al.  In search of optimal long-term female hormone replacement: the potential of selective estrogen receptor modulators. , 1997, Hormone research.

[60]  David Handelsman,et al.  A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency. , 2001, The Journal of clinical endocrinology and metabolism.

[61]  A. Baron,et al.  Polycystic Ovary Syndrome Is Associated With Endothelial Dysfunction , 2001, Circulation.

[62]  J. K. Lloyd,et al.  Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis , 1992, The Lancet.

[63]  H. Tunstall-Pedoe,et al.  Myocardial Infarction and Coronary Deaths in the World Health Organization MONICA Project: Registration Procedures, Event Rates, and Case‐Fatality Rates in 38 Populations From 21 Countries in Four Continents , 1994, Circulation.

[64]  K. Chatterjee,et al.  Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo. , 1996, Circulation.

[65]  Y. Ouchi,et al.  Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. , 1995, Circulation.

[66]  W. Weintraub,et al.  Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. , 1995, The New England journal of medicine.

[67]  M. Lewis,et al.  Endothelium‐derived relaxing factor alters calcium fluxes in rabbit aorta: a cyclic guanosine monophosphate‐mediated effect. , 1986, The Journal of physiology.

[68]  P. Poole‐Wilson,et al.  Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease , 1993, The Lancet.

[69]  A. Keech,et al.  Hormone replacement therapy is associated with improved arterial physiology in healthy post‐menopausal women , 1996, Clinical endocrinology.

[70]  K. Koh,et al.  Vascular Effects of Synthetic or Natural Progestagen Combined With Conjugated Equine Estrogen in Healthy Postmenopausal Women , 2001, Circulation.

[71]  G. New,et al.  Long-term estrogen therapy improves vascular function in male to female transsexuals. , 1997, Journal of the American College of Cardiology.

[72]  R. Karas,et al.  Human vascular smooth muscle cells contain functional estrogen receptor. , 1994, Circulation.

[73]  A. Yeung,et al.  Close relation of endothelial function in the human coronary and peripheral circulations. , 1995, Journal of the American College of Cardiology.

[74]  K. Spindler,et al.  Effect of Testosterone on Plaque Development and Androgen Receptor Expression in the Arterial Vessel Wall , 2001, Circulation.

[75]  S. Moncada EIGHTH GADDUM MEMORIAL LECTURE UNIVERSITY OF LONDON INSTITUTE OF EDUCATION DECEMBER 1980: BIOLOGICAL IMPORTANCE OF PROSTACYCLIN , 1982, British journal of pharmacology.

[76]  L. Viinikka,et al.  Nitric oxide as a challenge for the clinical chemistry laboratory. , 1996, Scandinavian journal of clinical and laboratory investigation.

[77]  R. Ross The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[78]  K. Korach,et al.  Endothelial dysfunction in a man with disruptive mutation in oestrogen-receptor gene , 1997, The Lancet.

[79]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[80]  D. Vaughan,et al.  Identification of authentic estrogen receptor in cultured endothelial cells. A potential mechanism for steroid hormone regulation of endothelial function. , 1996, Circulation.

[81]  I. Charles,et al.  Induction of calcium-dependent nitric oxide synthases by sex hormones. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[82]  D. Spiegelhalter,et al.  Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. , 1994, Journal of the American College of Cardiology.